[Computed tomography and scintigraphy in the evaluation of patients with myasthenia gravis (author's transl)]. 1981

D Fiore, and P R Biondetti, and R Ravasini, and A Camposampiero, and D D'Amico, and N Bassi

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009157 Myasthenia Gravis A disorder of neuromuscular transmission characterized by fatigable weakness of cranial and skeletal muscles with elevated titers of ACETYLCHOLINE RECEPTORS or muscle-specific receptor tyrosine kinase (MuSK) autoantibodies. Clinical manifestations may include ocular muscle weakness (fluctuating, asymmetric, external ophthalmoplegia; diplopia; ptosis; and weakness of eye closure) and extraocular fatigable weakness of facial, bulbar, respiratory, and proximal limb muscles. The disease may remain limited to the ocular muscles (ocular myasthenia). THYMOMA is commonly associated with this condition. Anti-MuSK Myasthenia Gravis,MuSK MG,MuSK Myasthenia Gravis,Muscle-Specific Receptor Tyrosine Kinase Myasthenia Gravis,Muscle-Specific Tyrosine Kinase Antibody Positive Myasthenia Gravis,Myasthenia Gravis, Generalized,Myasthenia Gravis, Ocular,Anti MuSK Myasthenia Gravis,Generalized Myasthenia Gravis,Muscle Specific Receptor Tyrosine Kinase Myasthenia Gravis,Muscle Specific Tyrosine Kinase Antibody Positive Myasthenia Gravis,Myasthenia Gravis, Anti-MuSK,Myasthenia Gravis, MuSK,Ocular Myasthenia Gravis
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D012645 Selenomethionine Diagnostic aid in pancreas function determination. Butanoic acid, 2-amino-4-(methylseleno)-,Radioselenomethionine,Selenomethionine Se 75,Selenomethionine Hydrochloride, (S)-Isomer,Selenomethionine, (+,-)-Isomer,Selenomethionine, (R)-Isomer,Selenomethionine, (S)-Isomer,Sethotope,Se 75, Selenomethionine
D013950 Thymus Gland A single, unpaired primary lymphoid organ situated in the MEDIASTINUM, extending superiorly into the neck to the lower edge of the THYROID GLAND and inferiorly to the fourth costal cartilage. It is necessary for normal development of immunologic function early in life. By puberty, it begins to involute and much of the tissue is replaced by fat. Thymus,Gland, Thymus,Glands, Thymus,Thymus Glands
D013952 Thymus Hyperplasia Enlargement of the thymus. A condition described in the late 1940's and 1950's as pathological thymic hypertrophy was status thymolymphaticus and was treated with radiotherapy. Unnecessary removal of the thymus was also practiced. It later became apparent that the thymus undergoes normal physiological hypertrophy, reaching a maximum at puberty and involuting thereafter. The concept of status thymolymphaticus has been abandoned. Thymus hyperplasia is present in two thirds of all patients with myasthenia gravis. (From Segen, Dictionary of Modern Medicine, 1992; Cecil Textbook of Medicine, 19th ed, p1486) Hyperplasia of Thymus Gland,Thymic Hyperplasia,Gland Hyperplasia, Thymus,Gland Hyperplasias, Thymus,Hyperplasia, Thymic,Hyperplasia, Thymus,Hyperplasias, Thymic,Thymic Hyperplasias,Thymus Gland Hyperplasia,Thymus Gland Hyperplasias
D013953 Thymus Neoplasms Tumors or cancer of the THYMUS GLAND. Cancer of Thymus,Thymus Cancer,Thymus Tumors,Cancer of the Thymus,Neoplasms, Thymic,Neoplasms, Thymus,Thymic Cancer,Thymic Neoplasms,Thymic Tumors,Cancer, Thymic,Cancer, Thymus,Cancers, Thymic,Cancers, Thymus,Neoplasm, Thymic,Neoplasm, Thymus,Thymic Cancers,Thymic Neoplasm,Thymic Tumor,Thymus Cancers,Thymus Neoplasm,Thymus Tumor,Tumor, Thymic,Tumor, Thymus,Tumors, Thymic,Tumors, Thymus

Related Publications

D Fiore, and P R Biondetti, and R Ravasini, and A Camposampiero, and D D'Amico, and N Bassi
January 1982, RoFo : Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin,
D Fiore, and P R Biondetti, and R Ravasini, and A Camposampiero, and D D'Amico, and N Bassi
September 1981, Casopis lekaru ceskych,
D Fiore, and P R Biondetti, and R Ravasini, and A Camposampiero, and D D'Amico, and N Bassi
November 1978, [Zasshi] [Journal]. Nihon Kyobu Geka Gakkai,
D Fiore, and P R Biondetti, and R Ravasini, and A Camposampiero, and D D'Amico, and N Bassi
April 1979, Nihon Igaku Hoshasen Gakkai zasshi. Nippon acta radiologica,
D Fiore, and P R Biondetti, and R Ravasini, and A Camposampiero, and D D'Amico, and N Bassi
August 1983, The Journal of computed tomography,
D Fiore, and P R Biondetti, and R Ravasini, and A Camposampiero, and D D'Amico, and N Bassi
April 1979, Nihon Igaku Hoshasen Gakkai zasshi. Nippon acta radiologica,
D Fiore, and P R Biondetti, and R Ravasini, and A Camposampiero, and D D'Amico, and N Bassi
January 1981, La Nouvelle presse medicale,
D Fiore, and P R Biondetti, and R Ravasini, and A Camposampiero, and D D'Amico, and N Bassi
February 1981, Zhonghua shen jing jing shen ke za zhi = Chinese journal of neurology and psychiatry,
D Fiore, and P R Biondetti, and R Ravasini, and A Camposampiero, and D D'Amico, and N Bassi
August 1979, Nippon Ganka Gakkai zasshi,
D Fiore, and P R Biondetti, and R Ravasini, and A Camposampiero, and D D'Amico, and N Bassi
April 1978, Revista medica de Chile,
Copied contents to your clipboard!